HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials (2013)
Source: Cancer Treatment Reviews. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA), REAÇÃO EM CADEIA POR POLIMERASE, MARCADOR MOLECULAR, QUIMIOTERAPIA ADJUVANTE, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DENT, Susan et al. HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials. Cancer Treatment Reviews, v. 39, n. 6, p. 622-631, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ctrv.2013.01.002. Acesso em: 15 nov. 2024.APA
Dent, S., Oyan, B., Honig, A., Mano, M., & Howell, S. (2013). HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials. Cancer Treatment Reviews, 39( 6), 622-631. doi:10.1016/j.ctrv.2013.01.002NLM
Dent S, Oyan B, Honig A, Mano M, Howell S. HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials [Internet]. Cancer Treatment Reviews. 2013 ; 39( 6): 622-631.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.ctrv.2013.01.002Vancouver
Dent S, Oyan B, Honig A, Mano M, Howell S. HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials [Internet]. Cancer Treatment Reviews. 2013 ; 39( 6): 622-631.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.ctrv.2013.01.002
